|
|
|
Sunday, August 03, 2008
GSK Seeks Fixed-price Deal with NHS
GlaxoSmithKline, the UK-based pharmaceutical group, plans to relaunch discussions with the Department of Health in an effort to reverse a decision that the National Health Service will not adopt its new cancer medicine Tyverb.
Please click here for more details.
|
|
